Encompass Health
347 hedge funds and large institutions have $4.45B invested in Encompass Health in 2022 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 41 increasing their positions, 269 reducing their positions, and 81 closing their positions.
421% more call options, than puts
Call options by funds: $18.7M | Put options by funds: $3.59M
12% less funds holding
Funds holding: 395 → 347 (-48)
15% less capital invested
Capital invested by funds: $5.21B → $4.45B (-$760M)
19.07% less ownership
Funds ownership: 117.56% → 98.5% (-19%)
50% less funds holding in top 10
Funds holding in top 10: 14 → 7 (-7)
54% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 81
85% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 269
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$135M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$127M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$117M |
| 4 |
GCM
Glenview Capital Management
New York
|
-$68.9M |
| 5 |
JP
Jana Partners
New York
|
-$47.9M |
EHC Hedge Fund Activity: Q3 2022 in Review
347 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Encompass Health (EHC) for Q3 2022, worth a combined $4.45B — down 15% from $5.21B a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of EHC and 37 opened new positions — a net loss of 44 holders — while 269 trimmed existing stakes and 41 added.
The largest buyer was William Blair Investment Management, adding an estimated $216M. The largest seller was BlackRock, cutting an estimated $135M.
- 347 institutional investors held Encompass Health (EHC) as of Q3 2022, down from 395 in Q2 2022.
- Funds reported $4.45B of Encompass Health stock for Q3 2022, down 15% quarter-over-quarter.
- 37 funds opened new Encompass Health positions in Q3 2022 and 81 closed out, a net change of -44 holders.
- The largest Encompass Health buyer in Q3 2022 was William Blair Investment Management, an estimated $216M added.
- The largest Encompass Health seller in Q3 2022 was BlackRock, an estimated $135M sold.
Based on aggregated 13F filings for Q3 2022.